Overview

Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.

Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine intratumoral concentration of kinase inhibitors upon 2 weeks of treatment in tumor tissue of patients.
Phase:
N/A
Details
Lead Sponsor:
VU University Medical Center
Treatments:
Dasatinib
Erlotinib Hydrochloride
Everolimus
Lapatinib
Sorafenib
Sunitinib
Vemurafenib